Skip to main content

Lymphoma

Meeting Highlights

Durable Responses to CAR T-Cell Therapy in B-Cell Lymphomas

Phoebe Starr, Medical Writer

Calquence (Acalabrutinib) Approved for Relapsed or Refractory Mantle-Cell Lymphoma in Adults

Imbruvica (Ibrutinib) First Drug Approved Specifically for Marginal-Zone Lymphoma and for Chronic Graft-versus-Host Disease

Yescarta (Axicabtagene Ciloleucel) Second CAR T-Cell Therapy Approved for Patients with Certain Types of Large B-Cell Lymphoma

1
2
3
4

Page 4 of 4
Results 31 - 34 of 34